跳至主要内容
临床试验/DRKS00031854
DRKS00031854尚未招募Unknown

Establishment of a prehabilitation process for patients with prostate cancer prior to curatively intended radical prostatectomy - an exploratory, prospective, controlled intervention study. - PreHab

Klinik und Poliklinik für Urologie und Kinderurologie Universitätsklinikum Bonn0 个研究点目标入组 252 人开始时间: 2023年9月22日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
252

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 85 Years(—)
性别
Male

入选标准

  • Patients who meet the following criteria may be included in the study:
  • Patients are between = 18 and = 85 years of age.
  • The patient has histologically confirmed prostate carcinoma.
  • The indication for radical prostatectomy is present and the patient wishes to undergo this procedure.
  • The patient is physically fit to participate in the planned procedures at the discretion of the investigator.
  • At the discretion of the investigator, the patient is mentally capable of understanding the consequences of participation in the study and can adequately evaluate the resulting obligations.
  • The patient gives written documented consent to study participation and the written documented informed consent form is available.
  • The patient is able to follow the study instructions and is likely to attend all required study visits (compliance).
  • The patient has the physical and cognitive ability to perform the physical training and participate in the psycho-oncology sessions, at the discretion of the investigator
  • The patient has the physical and cognitive ability to handle digital media and play internet videos, e.g., for whole body fitness training.
  • The patient has internet access and appropriate hardware to participate in the whole-body fitness training or to ensure transmission of data from the fitness watch vívosmart® 4 (by Garmin).

排除标准

  • Patients who meet any of the following criteria will not be included in the study:
  • The patient has a BMI > 40.
  • The patient is concurrently participating in another clinical trial or has participated in a clinical trial within the last 30 days that involved the use of an investigational drug.
  • The patient is or has been, to the knowledge or at the discretion of the investigator, dependent on medication, drugs, or alcohol.

研究者

发起方
Klinik und Poliklinik für Urologie und Kinderurologie Universitätsklinikum Bonn

相似试验